Effect of the soluble TNF-antagonist etanercept on tumor necrosis factor bioactivity and stability Academic Article uri icon

Overview

MeSH Major

  • Immunoglobulin G
  • Tumor Necrosis Factor-alpha

abstract

  • Etanercept increases the immunoreactive mass of TNF in heart failure patients, as well as augments TNF cytotoxicity in certain settings, thus suggesting one potential mechanism for the worsening heart failure in some patients who were receiving this agent.

publication date

  • December 2008

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC5439546

Digital Object Identifier (DOI)

  • 10.1111/j.1752-8062.2008.00013.x

PubMed ID

  • 20443835

Additional Document Info

start page

  • 142

end page

  • 5

volume

  • 1

number

  • 2